Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

This pilot trial is testing riluzole — a drug already approved for ALS — to see if it can help with the brain fog and memory problems that cancer survivors often experience after treatment. This side effect is sometimes called "chemo brain." Participants take riluzole and complete cognitive assessments to track any improvements. **You may be eligible if...** - You have been treated for breast cancer (any type of treatment) or received certain chemotherapy drugs (anthracyclines or platinum-based) for any cancer in the past 3 years - You feel your thinking or memory has gotten worse since your cancer diagnosis or treatment - You are 18 or older and can read/write in English, Chinese, Korean, Vietnamese, or Spanish **You may NOT be eligible if...** - You have cancer that has spread to the brain - You are pregnant, breastfeeding, or planning to become pregnant during the study - You are unwilling to complete cognitive tests Talk to your doctor to see if this trial is right for you.